Recombinant Anti-CLEC12A & Anti-CD3 Bispecific Antibody (Fab2) is composed of the Fab of the anti-CLEC12A monoclonal antibody and Fab of an antibody specific for CD3. A linker is added between the two Fab. The bispecific antibody is somewhat smaller than a whole IgG and therefore it can be cleared from the blood naturally at a faster rate. This BsAb can retarget of T cells to tumor cells. It was designed for the treatment of CLEC12A-positive AML.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
CROSS-L002 | Recombinant Anti-CLEC12A × Anti-CD3 Bispecific Antibody (CrossMab) | FuncS, Promising therapeutic agent | CrossMab |
There are currently no Customer reviews or questions for FAB-L010. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.